Recorded at SCbio’s 2025 annual conference, Heather and Lauren welcome Eric Perrault, the CEO of Kiyatec, which focuses on functional precision oncology. Eric discusses their exciting process, which aims to predict how individual cancer patients will respond to tailored therapies before treatment begins. We dive into their live cell therapy, partnerships with surgeons, and much more. Tune in to learn about cutting-edge developments in cancer treatment!
Press CTRL+C to copy embed code to clipboard
